Green Nicholas Stewart's Form 4 filing
Avid Bioservices, Inc. (CDMO) · filed Dec 27, 2024
- Accession no.
- 0001683168-24-009023
- Filed
- Dec 27, 2024
- Trade date
- Dec 25-26, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 10 derivative transactions. Open-market sales total $1.78M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Green Nicholas StewartCIK 0001817685 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 25, 2024 | Common Stock, $0.001 par value | MOption exerciseAcquired | +119,973 | –F2 | – | 119,973 | Direct | |
| Dec 25, 2024 | Common Stock, $0.001 par value | MOption exerciseAcquired | +183,558 | –F3 | – | 303,531 | Direct | |
| Dec 26, 2024 | Common Stock, $0.001 par value | SSaleDisposed | −57,675 | $12.22 | −$704,788.5 | 245,856 | Direct | |
| Dec 26, 2024 | Common Stock, $0.001 par value | SSaleDisposed | −88,236 | $12.22 | −$1,078,243.92 | 157,620 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −16,721 | $0.00 | $0 | 466,193 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −26,479 | $0.00 | $0 | 439,714 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −25,434 | $0.00 | $0 | 414,280 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −51,339 | $0.00 | $0 | 362,941 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −47,073 | $0.00 | $0 | 787,310 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −47,073 | $0.00 | $0 | 740,237 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −45,215 | $0.00 | $0 | 695,022 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −45,215 | $0.00 | $0 | 649,807 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −91,270 | $0.00 | $0 | 558,537 | Direct | |
| Dec 25, 2024 | Common Stock | DReturned to the companyDisposed | −91,270 | $0.00 | $0 | 467,267 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.
- F3
Each performance stock unit ("PSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
Referenced by the price of 1 transaction in Table I.